Andrea de Matteis, M.D.
NCI Naples, Division of Medical Oncology C
7
7
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Francesco Perrone, M.D., Ph.D.
NCI Naples, Clinical Trials Unit
Shared therapeutic areas:
Worked with same sponsors:
Herui Yao, PhD
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
min yan
Henan Cancer Hospital
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D.
NCI Naples, Clinical Trials Office
Shared therapeutic areas:
Worked with same sponsors:
Giuseppe D'Aiuto, M.D.
NCI Naples, Division of Surgical Oncology A
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
All 7 trials loaded